Why is Johnson & Johnson so invested in HIV research and what are you trying to achieve?

Jul 20th, 2016 MoJo 2 Views

Dr Paul Stoffels, Executive Vice President and Chief Scientific Officer for Johnson & Johnson, answers questions pertinent to the 2016 International AIDS Conference.